Answers are grounded in this paper and cite their sources.
These results indicate that inhibition of TOP2A is more efficacious by decreasing the mitochondrial metabolic reprogramming and thereby downregulating the key anti-apoptotic and pro-survival mediators. Thus, TOP2A represents an ideal therapeutic target and offers a potential treatment strategy for OSCC.
No takes yet. Share an insight, caveat, or question.
Kanagasabai et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: